Scientists have identified four new symptoms of coronavirus to look out for.
After conducting a study of more than one million people across England, they were able to identify additional symptoms of the virus.
These four are on top of the three main symptoms which are officially recognised by the NHS, which are loss of smell and taste, a new persistent cough, and a fever.
Following the study, scientists suggest that chills, a loss of appetite, headaches, and muscle aches could also be signs of Covid-19, meaning many people who potentially had the virus won’t have got tested.
Researchers used swab tests and questionnaires to conduct the study, which were collected between June 2020 and January 2021.
Imperial College London, who spearheaded the React study, discovered there was a variation in symptoms which came with age.
Chills were recorded across all ages, while headaches were mainly seen in kids and teenagers aged five to 17, and muscle aches were mostly spotted in those aged between 18 and 54.
Appetite loss was recorded more in 18-54 year olds as well as people aged 55 and over, and five to 17 year olds who had the virus were less likely to have a fever, persistent cough or appetite loss.
Roughly 60% of participants in the study who tested positive for coronavirus didn’t report any symptoms during the week leading to the test.
The director of the React programme at Imperial, Professor Paul Elliott, said: “These new findings suggest many people with Covid-19 won’t be getting tested – and therefore won’t be self-isolating – because their symptoms don’t match those used in current public health guidance to help identify infected people.
“We understand that there is a need for clear testing criteria, and that including lots of symptoms which are commonly found in other illnesses like seasonal flu could risk people self-isolating unnecessarily.
“I hope that our findings on the most informative symptoms mean that the testing programme can take advantage of the most up-to-date evidence, helping to identify more infected people.”
While people are currently only advised to get a test if they have one or more of the three classic symptoms, researchers estimate that if people with the additional four symptoms were also tested they’d pick up three-quarters of symptomatic infections, rather than just half.
Travel traffic light system to be scrapped as big changes for holidaymakers announced
A number of countries including Turkey are also been removed from the red list
Travel restrictions for the UK will be majorly relaxed from next month onwards, the transport secretary has announced.
According to Sky News, the current traffic light system of red, amber and green countries will be completely scrapped and replaced with one red list only from October 4th.
Also from that date, travellers will no longer need to take pre-departure tests for travelling into England from abroad.
And, from the end of October, fully vaccinated passengers from non-red list countries will be able to replace day-two PCR tests with cheaper lateral flow tests.
Anyone testing positive, however, will still need to isolate and take a free PCR test to help identify new variants.
From 4am on September 22nd, the following eight destinations will be removed from the red list; Turkey, Egypt, Kenya, Pakistan, Bangladesh, Oman, The Maldives and Sri Lanka.
Transport Secretary Grant Shapps said: “Today’s changes mean a simpler, more straightforward system. One with less testing and lower costs, allowing more people to travel, see loved ones or conduct business around the world while providing a boost for the travel industry.
“Public health has always been at the heart of our international travel policy and with over 44 million people fully vaccinated in the UK, we are now able to introduce a proportionate updated structure that reflects the new landscape.”
Scientists at University of Manchester make massive breakthrough on dementia
A massive step forward in the search for a cure for dementia
Scientists at the University of Manchester have discovered that a common blood pressure drug that could help people suffering from vascular dementia.
Amlodepine is used to treat high blood pressure, but could potentially serve a purpose in tackling a type of vascular dementia caused by damaged and ‘leaky’ small blood vessels in the brain, according to research part-funded by the British Heart Foundation and published today in the Journal of Clinical Investigation.
High blood pressure is known to be the main risk factor in developing vascular dementia.
Researchers came to their conclusion by analysing blood flow in the brains of mice with high blood pressure and vascular damage in the brain.
Mice treated with amlodipine had better blood flow to more active areas of the brain. Their arteries were able to widen, allowing more oxygen and nutrients to reach the parts of the brain that needed it most.
The team also discovered for the first time that high blood pressure decreases the activity of a protein called ‘Kir2.1’ that is present in cells lining the blood vessels and increases blood flow to active areas of the brain.
They now hope to trial amlodipine as an effective treatment for vascular dementia in humans, making it the first clinically proven treatment for vascular dementia if successful.
Dr Adam Greenstein, Clinical Senior Lecturer in Cardiovascular Sciences at the University of Manchester, who led the Manchester team, told ITV News: “The way vascular dementia develops has remained a mystery until now, and there are currently no clinically proven treatments.
“Patients are presenting with symptoms of vascular dementia earlier than ever before, and with further research we could potentially offer those patients hope to prevent the progression of this life-changing disease.”
Professor Metin Avkiran, Associate Medical Director at the British Heart Foundation, added: “The way to better understand this devastating disease and find new treatments is through research. This study is a vital step forward towards finding new ways of stopping vascular dementia from progressing.
“These new discoveries highlight the major role that high blood pressure plays in developing the disease and shed light on how this occurs and might be prevented in the future.”
Government plan return of imperial pounds and ounces in supermarkets
A Brexit document includes plans to review the EU ban on markings and sales in pounds and ounces
As a result of post-Brexit changes to EU laws, supermarkets could soon see the return of imperial pounds and ounces for their food produce.
Prime Minister Boris Johnson had previously said that he would bring imperial units back to shops as part of his pitch to voters in the 2019 general election, promising ‘an era of generosity and tolerance towards traditional measurements’.
And now, in the wake of Brexit, the UK faces a ban on labelling products with imperial units as part of a post-Brexit plan according to Brexit minister Lord Frost, who also claims pint glasses could be voluntarily stamped with a crown.
A document titled ‘Brexit opportunities: regulatory reforms’ includes plans to review the EU ban on markings and sales in pounds and ounces, with legislation set to come ‘in due course’ and to permit the voluntary printing of the crown stamp on pint glasses, as per The Independent.
This comes after Lord Frost claimed that ‘gloom-mongers’ had been proved wrong following the UK’s exit from the EU, with him reportedly saying to a peer: “A lot of things haven’t happened that the gloom-mongers said would happen and I don’t think are going to happen.
He added: “This economy and this country is prospering vastly already under the arrangements that we are putting in place. High standards need to reflect the context we are operating in.
“I am sure there will be change, but don’t believe those changes will result in regression of standards.”
This review comes amid crippling food shortages in supermarkets across the UK, which is believed to be a result of both Brexit and Covid.
Other big retailers such as McDonald’s, Greggs, the Co-op and Ikea have also struggled to supply products to their customers in recent weeks.